Replies to post #1068 on Idenix Pharmaceuticals (IDIX)

[DewDiligence]

>I maintain that the victor [for second-line treatment] is currently Hepsera based on scientific principles, until IDIX presents data to the contrary.<

No argument there, but NVS/IDIX are running the second-line trial I cited for exactly this reason.